Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappa B activation.
about
Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection.Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral stateCritical care medicine in AJRCCM 2002.Pediatrics, surfactant, and cystic fibrosis in AJRCCM 2002.Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis.High vapor pressure perfluorocarbons cause vesicle fusion and changes in membrane packing.Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation.Perfluorocarbons decrease Chlamydophila pneumoniae-mediated inflammatory responses of rat type II pneumocytes in vitro.Anti-inflammatory effects of perfluorocarbon compounds.Influence of partial liquid ventilation on bacterial growth and alveolar expansion in newborn rabbits with group B-streptococcal pneumonia.Systemic administration of FC-77 dampens ischemia-reperfusion-induced acute lung injury in rats.Protective Role of Nuclear Factor Erythroid 2-Related Factor 2 Against Respiratory Syncytial Virus and Human Metapneumovirus Infections.Nuclear factor κB1/RelA mediates the inflammation and/or survival of human airway exposed to sulfur mustard.
P2860
Q33374284-540C947F-BFDB-4FEE-96FA-84BDA36370B4Q34557849-D6D2EE72-5999-463B-896C-2BC436A7E0E4Q35055439-D9CBD7EB-0CDF-43BB-9713-94BC01B72044Q35055452-FFC3E898-76A4-4B22-9B19-88577209E4E0Q35107695-4DA363E4-DA20-4057-8B8B-1428506B53FDQ36957316-8ADFA91F-0554-4CE5-B828-3CEC21345978Q37110768-B51A55E4-C3CC-4277-92E2-5040423A425CQ37861823-A671DC69-03C8-4908-BBE8-6B44D21923EAQ43061651-0F9F5F56-D38F-40CD-BF93-4D94CA0815C3Q44557713-E1DC63DA-E419-4130-88C0-C37240D7CC67Q50872583-92379047-1531-4C38-A58E-7E1656991AFEQ54217591-0D2CD1CB-C3E0-43C7-B082-14EF64ABB74BQ54348334-D2305D5C-5199-447A-85BF-387237F08825
P2860
Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappa B activation.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Perflubron reduces lung inflam ...... ear factor-kappa B activation.
@en
Perflubron reduces lung inflam ...... ear factor-kappa B activation.
@nl
type
label
Perflubron reduces lung inflam ...... ear factor-kappa B activation.
@en
Perflubron reduces lung inflam ...... ear factor-kappa B activation.
@nl
prefLabel
Perflubron reduces lung inflam ...... ear factor-kappa B activation.
@en
Perflubron reduces lung inflam ...... ear factor-kappa B activation.
@nl
P2093
P2860
P356
P1476
Perflubron reduces lung inflam ...... ear factor-kappa B activation.
@en
P2093
Frances Nesti
Hans-Juergen Dieterich
Helene A Haeberle
Roberto P Garofalo
Zoran Gatalica
P2860
P304
P356
10.1164/RCCM.2109077
P407
P577
2002-05-01T00:00:00Z